Deliver Your News to the World

Rottenstein Law Group Produces Videos to Raise Public Awareness About Paxil History, Dangers and Litigation


WEBWIRE

(New York, NY, September 7, 2011) The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the antidepressant drug Paxil (paroxetine) has launched a series of brief, informative videos intended to inform the public about the history of Paxil, the potential dangers to those who take it, and litigation concerning the drug.
The Rottenstein Law Group recently launched a Paxil Lawsuit information Web site complete with social media features that allow for easy sharing of information pertaining to the dangers of taking Paxil on popular sites like Facebook and Twitter. The firm has now added videos that will further educate the public. In keeping with the goal of allowing visitors the ability to share pertinent information available on the site, these videos, produced by the Rottenstein Law Group, can be downloaded and viewed on all manner of devices, including smart phones.
Numerous studies have linked Paxil to a range of birth defects in children born to mothers who took the drug while pregnant. These include: clubbed foot; cleft lip/palate; delayed development; persistent pulmonary hypertension; gastroschisis; heart defects; skull defects and brain/spinal cord defects. Additionally, it has been suggested that Paxil may also cause premature birth and miscarriage, and that children exposed to Paxil in utero may experience withdrawal symptoms after birth.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.



WebWireID145205




 
 Paxil
 depression
 ssri
 birth defects
 antidepressants


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.